Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1980 1
1981 1
1982 12
1983 24
1984 6
1985 8
1986 16
1987 8
1988 12
1989 11
1990 18
1991 10
1992 8
1993 7
1994 10
1995 17
1996 3
1997 4
1998 10
1999 7
2000 12
2001 12
2002 11
2003 21
2004 14
2005 16
2006 20
2007 13
2008 6
2009 14
2010 18
2011 17
2012 19
2013 25
2014 21
2015 19
2016 29
2017 36
2018 36
2019 27
2020 34
2021 39
2022 37
2023 27
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

673 results

Results by year

Filters applied: . Clear all
Page 1
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial.
Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A, Tokioka F, Kadowaki T, Watanabe A, Fukui M, Kitajima T, Sato S, Tsuda T, Kishimoto N, Kita H, Mori Y, Nakayama M, Takahashi K, Tsuboi T, Yoshida M, Hataji O, Fuke S, Kagajo M, Nishine H, Kobayashi H, Nakamura H, Okuda M, Tachibana S, Takata S, Osoreda H, Minami K, Nishimura T, Ishida T, Terada J, Takeuchi N, Kohashi Y, Inoue H, Nakagawa Y, Kikuchi T, Tomii K. Nagata K, et al. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1326-1335. doi: 10.1164/rccm.202201-0199OC. Am J Respir Crit Care Med. 2022. PMID: 35771533 Free PMC article. Clinical Trial.
Methods: We enrolled 104 participants (aged 40 yr) with daytime hypercapnia (Global Initiative for Chronic Obstructive Lung Disease stages 2-4) receiving long-term oxygen therapy (16 h/d for 1 mo) and randomly assigned them to high-flow nasal cannula/long-term oxygen thera …
Methods: We enrolled 104 participants (aged 40 yr) with daytime hypercapnia (Global Initiative for Chronic Obstructive Lung Disease stages 2 …
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS. Fajgenbaum DC, et al. Blood. 2017 Mar 23;129(12):1646-1657. doi: 10.1182/blood-2016-10-746933. Epub 2017 Jan 13. Blood. 2017. PMID: 28087540 Free PMC article.
Retraction. Tanji H, Ishikawa C, Sawada S, Nakachi S, Takamatsu R, Matsuda T, Okudaira T, Uchihara J-N, Ohshiro K, Tanaka Y, Senba M, Uezato H, Ohshima K, Duc Dodon M, Wu K-J, Mori N. Aberrant expression of the transcription factor Twist in adult T-cell leukemia [published online ahead of print January 13, 2010]. Blood. doi:10.1182/blood-2009-07-232231.
[No authors listed] [No authors listed] Blood. 2010 Aug 26;116(8):1386. doi: 10.1182/blood-2010-06-292862. Epub 2010 Jun 23. Blood. 2010. PMID: 20574045 Free article. No abstract available.
Ethyl α-l-sorboside.
Nagayama N, Taniguchi N, Matsumoto M, Takeshita K, Ishii T. Nagayama N, et al. IUCrdata. 2020 Dec 18;5(Pt 12):x201625. doi: 10.1107/S2414314620016259. eCollection 2020 Dec. IUCrdata. 2020. PMID: 36337337 Free PMC article.
Ethyl l-sorboside, C(8)H(16)O(6), was prepared from the rare sugar l-sorbose, C(6)H(12)O(6), and crystallized. ...
Ethyl l-sorboside, C(8)H(16)O(6), was prepared from the rare sugar l-sorbose, C(6)H(12)O(6), and crystallized. ...
Comment to the paper: Acceleration of peripheral nerve regeneration using nerve conduits in combination with induced pluripotent stem cell technology and a basic fibroblast growth factor drug delivery system by M. Ikeda, T. Uemura, K. Takamatsu, M. Okada, K. Kazuki, Y. Tabata, Y. Ikada, H. Nakamura, J Biomed Mater Res A. 2013 Jun 3 doi: 10.1002/jbm.a.34816.
Haastert-Talini K, Grothe C. Haastert-Talini K, et al. J Biomed Mater Res A. 2014 Apr;102(4):1219-20. doi: 10.1002/jbm.a.35082. Epub 2014 Feb 4. J Biomed Mater Res A. 2014. PMID: 24442927 No abstract available.
Methyl α-l-sorboside monohydrate.
Matsumoto M, Nagayama N, Hirose R, Takeshita K, Ishii T. Matsumoto M, et al. IUCrdata. 2021 Dec 21;6(Pt 12):x211325. doi: 10.1107/S2414314621013250. eCollection 2021 Dec. IUCrdata. 2021. PMID: 36337594 Free PMC article.
Methyl l-sorboside monohydrate, C(7)H(14)O(6).H(2)O, was prepared from the rare sugar l-sorbose, C(6)H(12)O(6), and crystallized. ...
Methyl l-sorboside monohydrate, C(7)H(14)O(6).H(2)O, was prepared from the rare sugar l-sorbose, C(6)H(12)O(6), and cry …
673 results